Open Research will be updating the system on Monday, 25 May 2026, from 8:15 to 8:45 AM. We apologise for any inconvenience caused.

Extending drug ethno-epidemiology using agent-based modelling

dc.contributor.authorMoore, Daviden_AU
dc.contributor.authorDray, Anneen_AU
dc.contributor.authorGreen, Rachelen_AU
dc.contributor.authorHudson, Susanen_AU
dc.contributor.authorJenkinson, Rebeccaen_AU
dc.contributor.authorSiokou, Christineen_AU
dc.contributor.authorPerez, Pascalen_AU
dc.contributor.authorMaher, Lisaen_AU
dc.contributor.authorDietze, Paulen_AU
dc.contributor.authorBammer, Gabrieleen_AU
dc.date.accessioned2015-12-08T22:36:08Z
dc.date.issued2009
dc.date.updated2016-02-24T09:52:34Z
dc.description.abstractAims To show how the inclusion of agent-based modelling improved the integration of ethno-epidemiological data in a study of psychostimulant use and related harms among young Australians. Methods Agent-based modelling, ethnographic fieldwork, in-depth interviews and epidemiological surveys. Setting Melbourne, Perth and Sydney, Australia. Participants Club drug users in Melbourne, recreational drug users in Perth and street-based injecting drug users in Sydney. Participants were aged 18-30 years and reported monthly or more frequent psychostimulant use. Findings Agent-based modelling provided a specific focus for structured discussion about integrating ethnographic and epidemiological methods and data. The modelling process was underpinned by collective and incremental design principles, and produced 'SimAmph', a data-driven model of social and environmental agents and the relationships between them. Using SimAmph, we were able to test the probable impact of ecstasy pill-testing on the prevalence of harms - a potentially important tool for policy development. The study also navigated a range of challenges, including the need to manage epistemological differences, changes in the collective design process and modelling focus, the differences between injecting and non-injecting samples and concerns over the dissemination of modelling outcomes. Conclusions Agent-based modelling was used to integrate ethno-epidemiological data on psychostimulant use, and to test the probable impact of a specific intervention on the prevalence of drug-related harms. It also established a framework for collaboration between research disciplines that emphasizes the synthesis of diverse data types in order to generate new knowledge relevant to the reduction of drug-related harms.
dc.identifier.issn0965-2140
dc.identifier.urihttp://hdl.handle.net/1885/35130
dc.publisherCarfax Publishing, Taylor & Francis Group
dc.sourceAddiction
dc.subjectKeywords: 3,4 methylenedioxymethamphetamine; psychostimulant agent; agent based modelling; Australia; drug use; ethnography; health care policy; health survey; human; interview; mathematical model; prevalence; review; Adolescent; Adult; Amphetamine-Related Disorder Agent-based modelling; Australia; Drug policy; Ethno-epidemiology; Psychostimulants
dc.titleExtending drug ethno-epidemiology using agent-based modelling
dc.typeJournal article
local.bibliographicCitation.lastpage1997
local.bibliographicCitation.startpage1991
local.contributor.affiliationMoore, David, Curtin University of Technology
local.contributor.affiliationDray, Anne, College of Asia and the Pacific, ANU
local.contributor.affiliationGreen, Rachel, Curtin University of Technology
local.contributor.affiliationHudson, Susan, University of New South Wales
local.contributor.affiliationJenkinson, Rebecca, Monash University
local.contributor.affiliationSiokou, Christine , Curtin University of Technology
local.contributor.affiliationPerez, Pascal, College of Asia and the Pacific, ANU
local.contributor.affiliationBammer, Gabriele, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationMaher, Lisa, University of New South Wales
local.contributor.affiliationDietze, Paul, Monash University
local.contributor.authoruidDray, Anne, u4294803
local.contributor.authoruidPerez, Pascal, u4048171
local.contributor.authoruidBammer, Gabriele, u8401731
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor111706 - Epidemiology
local.identifier.ariespublicationu3154186xPUB121
local.identifier.citationvolume104
local.identifier.doi10.1111/j.1360-0443.2009.02709.x
local.identifier.scopusID2-s2.0-70449432797
local.identifier.thomsonID000271625500007
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Moore_Extending_drug_2009.pdf
Size:
154.86 KB
Format:
Adobe Portable Document Format